Serrated polyps and colorectal cancer: new pathway to malignancy.

Department of Pathology, The University of Chicago, Chicago, IL 60637, USA.
Annual Review of Pathology Mechanisms of Disease (Impact Factor: 22.13). 02/2009; 4:343-64. DOI: 10.1146/annurev.pathol.4.110807.092317
Source: PubMed

ABSTRACT Until recently, two major forms of colorectal epithelial polyp were recognized: the adenoma and the hyperplastic polyp. Adenomas were perceived to represent the precursor to colorectal cancer, whereas hyperplastic polyps were viewed as innocuous lesions with no potential for progression to malignancy. We now recognize, however, that the lesions formerly classified as hyperplastic actually represent a heterogeneous group of polyps, some of which have a significant risk for neoplastic transformation. These serrated polyps include not only hyperplastic polyps but also traditional serrated adenomas and sessile serrated adenomas. These polyps demonstrate characteristic molecular alterations not commonly seen in colorectal adenomas, and they probably progress to colorectal cancer by means of a new pathway: the serrated neoplasia pathway. The morphologic features of serrated colorectal lesions, the molecular alterations that characterize them, and their role in colorectal cancer development are discussed herein.

1 Follower
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: Cyclooxygenase-2 (COX-2) expression has been observed in a substantial percentage of classical adenomas of the large bowel. The aim of the study was to assess and compare the expression of COX-2 in serrated polyps of the colon. One hundred and nineteen serrated polyps were analyzed. There were 83 hyperplastic polyps (HP), 19 sessile serrated polyps (SSP) and 17 traditional serrated adenomas (TSA). COX-2 expression was assessed semi-quantitatively (0-2) and each lesion was fully characterized in terms of anatomical location, size, histology, age and sex of the patient. The general estimating equation (GEE) model with logit link was used in the statistical analysis. Epithelial expression of COX-2 was found in 85/119 serrated polyps (71.43%): 57/83 (68.67%) HP, 16/19 (84.21%) SSP, and 12/17 (70.59%) TSA. In HP and SSP it was predominantly of weak (49/83 HP, 12/19 SSP), whereas in TSA it was mainly of medium/strong intensity (8/17). The TSA category was associated with more frequent COX-2 expression (OR = 7.00, 95% CI: 1.49-32.88, p = 0.014) than HP, but such relation was not found for SSP vs. HP (p > 0.1). No associations between COX-2 expression and clinical parameters were found. Immunohistochemical COX-2 expression cannot serve as a diagnostic adjunct to differentiate HP and SSP.
    Contemporary Oncology / Wspólczesna Onkologia 12/2014; 18(6):409-13. DOI:10.5114/wo.2014.47907 · 0.22 Impact Factor
  • [Show abstract] [Hide abstract]
    ABSTRACT: Die beiden Hauptwege der kolorektalen Karzinogenese umfassen die klassische Adenom-Karzinom-Sequenz und die serratierte Route. In der klassischen Adenom-Karzinom-Sequenz findet sich initial häufig eine Mutation des APC-Gens, die zu einer Aktivierung des WNT/β-Catenin-Signalwegs führt. Ist der WNT-Signalweg aktiviert, vermittelt β-Catenin die Transkription verschiedener Faktoren, die die Migration, Invasion und Proliferation der Zellen bedingen. Obwohl in allen Tumorzellen eine APC-Mutation auftritt, findet sich in den Tumoren ein heterogenes Verteilungsmuster von β-Catenin, welches auch einen wichtigen prognostischen Marker darstellt. Ein ähnliches Bild zeigt sich für γ-Catenin, das unabhängig von β-Catenin exprimiert wird. Deutlich homogener ist dagegen die Expression von TCF4 und LEF1, der beiden Hauptbindungspartner von β- und γ-Catenin, die ebenfalls wichtige prognostische Marker darstellen. Im TRAIL-Signalweg, der therapeutisch interessant ist, zeigt sich häufig ein Verlust der Hauptrezeptoren TRAIL-R1 und TRAIL-R2. Zudem korreliert die Membranständigkeit beider Faktoren mit einem besseren Gesamtüberleben. Diese Ergebnisse könnten therapeutisch relevant sein hinsichtlich einer Therapie mit rekombinanten TRAIL-Molekülen, die an TRAIL-R1 und TRAIL-R2 binden. In der serratierten Route spielt initial eine onkogen vermittelte Seneszenz eine wesentliche Rolle, die durch eine Aktivierung des KRAS- oder BRAF-Onkogens vermittelt wird. Diese Seneszenzblockade wird durch eine Hypermethylierung am p16INK4a-Promoter durchbrochen und führt zur Entwicklung invasiver Tumoren. Auch SIRT1 und c-Myc tragen zu einer Progression der Läsionen in der serratierten Route bei und werden sowohl durch den RAS/RAF/MAPK-Kinase-Signalweg als auch durch den WNT/β-Catenin-Signalweg aktiviert. Abstract The main signaling pathways of colorectal carcinogenesis encompass the classical adenoma-carcinoma sequence and the serrated route. In the classical adenoma-carcinoma sequence there are initially frequent mutations of the APC gene which lead to an activation of the WNT signaling pathway. When the WNT signaling pathway is activated β-catenin mediates the transcription of diverse factors which cause migration, invasion and proliferation of cells. Although APC mutations occur in all tumor cells, a heterogeneous distribution pattern of β-catenin is found in tumors and β-catenin also represents an important prognostic marker. A similar picture is found for γ-catenin which is expressed independently from β-catenin. Clearly more homogeneous is the expression of TCF4 and LEF1 which are the main binding partners of β-catenin and γ-catenin and are likewise important prognostic markers. The TRAIL signaling pathway is therapeutically interesting and within this pathway loss of the main receptors TRAIL-R1 and TRAIL-R2 is frequently found. Furthermore, the membranous localization of both factors correlates with a better overall survival. These results might be therapeutically relevant with respect to therapy with recombinant TRAIL molecules binding to TRAIL-R1 and TRAIL-R2. In the serrated route oncogen-induced senescence caused by mutations of the KRAS and BRAF oncogenes initially plays an important role. This senescence blockade is overcome by hypermethylation of the p16INK4a promoter and leads to the development of invasive tumors. The SIRT1 and c-Myc genes also contribute to progression of lesions in the serrated route and are activated through the RAS/RAF/MAPK-kinase signaling pathway as well as the WNT/β-catenin signaling pathway.
    Der Pathologe 11/2013; 34(S2):269-273. DOI:10.1007/s00292-013-1821-y · 0.64 Impact Factor
  • Source


Available from